semperit group investor presentation h1 2013

H1 2013 SEMPERIT GROUP INVESTOR PRESENTATION 13 August 2013

1

Key Highlights H1 2013: Excellent revenue and earnings growth

Investor Presentation I 13 August 2013 I Investor Relations 2

Revenue growth of +10.2% to EUR 451.4m in H1 2013 Strong performance and higher profitability in both sectors

despite tense environment Double digit earnings growth:

EBITDA +21.9% to EUR 65.8m, EBIT +16.5% to EUR 43.7m

Best half-year results despite weak economy Revenue by segments H1 2013 (vs. H1 2012)

Sempermed 48% (44%)

Semperform 14% (15%)

Semper- trans 18% (17%)

Semperflex 20% (23%)

Europe 62% (60%)

Asia, Africa, RoW 16% (15%)

North & South America 22% (25%)

Raw material markets with lower prices due to weak demand in H1 2013

First signs of bottoming out by the middle of the year

Medical Sector Unchanged growth of the gloves market (non-cyclical trend) Price pressure continued due to overcapacities and competition Industrial Sector Relevant customer industries (energy, construction, engineering)

were still influenced by weak economy Semperit gained market shares and achieved excellent profitability

Lower prices for raw materials

Economic impact on Semperit Group

Revenue by regions H1 2013 (vs. H1 2012)

Medical Sector: Global growth primarily based on Latexx Partners integration


Average market growth of 5-7% p.a.

Global demand for nitrile gloves is growing faster than for natural latex gloves

Continued pricing pressure due to excess capacity

Higher sales volumes due to Latexx Partners and generally better sales performance

Sales of examination gloves increased at double-digit rates

Growth in medical as well as non-medical areas (industrial and consumer goods sector)

Sempermed headquarters in Singapore now fully operational

Good demand for surgical gloves in core markets

Overall capacity utilisation in Sempermed above 80%

Market

Business development

Integration of Latexx Partners

Integration of Latexx Partners well proceeding

Delisted in June 2013, remaining shareholders can sell their shares at unchanged conditions until August 30, 2013

Semperit holds a stake of more than 96% (fully diluted, as of 30.06.2013)

Industrial Sector: Strong performance despite weak economy


Semperflex performed satisfactorily in a difficult economic environment

Good orders and almost fully utilised capacity in Europe

Gradual recovery in North America and Asia, except China

Hydraulic Hoses: market share and new customers gained despite shrinking markets

Industrial Hoses: higher market shares, first sales in Asia and the USA

Business driven by long-term megatrends and new products

Satisfactory demand but project business slower than H1 2012

EUR 40m investment in Polish plant Belchatow in the next years

Capacities well utilised until Q4 2013

Semperflex

Sempertrans

Positive development despite difficult market and negative price effects

Volume growth in almost all business units

Construction profiles with increased market share in Europe

Handrails with expanded ASM market shares in US and Europe

Semperform

Financial Performance

5

H1 2013: Best first half-year in company history


1) Including Corporate Center: costs of EUR 7.8m in H1 2013 (EUR 6.3m in H1 2012) 2) Earnings per share attributable to shareholders of Semperit AG Holding

H1 2013 H1 2012 %

218.3 182.2 +19.8%

28.2 18.5 +52.9%

12.9% 10.1% +2.8 pp

17.1 12.3 +39.6%

7.8% 6.7% +1.1 pp

in EUR m

Revenue

EBITDA

EBITDA margin

EBIT

EBIT margin

Earnings after tax

Earnings per share in EUR2)

CAPEX

Employees (per reporting date)

Medical Sector Industrial Sector

H1 2013 H1 2012 %

233.1 227.6 +2.4%

45.1 41.6 +8.6%

19.4% 18.3% +1.1 pp

34.3 31.5 +9.0%

14.7% 13.8% +0.9 pp

H1 2013 H1 2012 %

451.4 409.8 +10.2%

65.8 53.9 +21.9%

14.6% 13.2% +1.4 pp

43.7 37.5 +16.5%

9.7% 9.2% +0.5 pp

28.2 23.9 +18.3%

1.36 1.16 +17.3%

19.9 16.7 +18.9%

10,039 8,115 +23.7%

Group Total1)

Q2 2013: Highlights of a new record quarter


1) Including Corporate Center: costs of EUR 4.5m in Q2 2013 (EUR 4.4m in Q2 2012) 2) Earnings per share attributable to shareholders of Semperit AG Holding

Q2 2013 Q2 2012 %

111.6 94.2 +18.4%

16.0 11.9 +33.9%

14.3% 12.7% +1.6 pp

10.0 8.6 +17.0%

9.0% 9.1% -0.1 pp

in EUR m

Revenue

EBITDA

EBITDA margin

EBIT

EBIT margin

Earnings after tax

Earnings per share in EUR2)

CAPEX

Employees (per reporting date)

Medical Sector Industrial Sector

Q2 2013 Q2 2012 %

124.7 113.7 +9.6%

24.9 21.9 +13.3%

19.9% 19.3% +0.6 pp

19.4 16.8 +15.2%

15.6% 14.8% +0.8 pp

Q2 2013 Q2 2012 %

236.2 208.0 +13.6%

36.4 29.6 +23.2%

15.4% 14.2% +1.2 pp

24.9 21.0 +18.9%

10.6% 10.1% +0.5 pp

15.8 12.3 +28.5%

0.76 0.60 +27.4%

10.1 8.2 +23.4%

10,039 8,115 +23.7%

Group Total1)

Medical Sector: Revenue and earnings growth in highly competitive markets


in EUR m H1 2013 H1 2012 %

Revenue 218.3 182.2 +19.8%

EBITDA 28.2 18.5 +52.9%

EBITDA margin 12.9% 10.1% +2.8 pp

Depreciation -11.1 -6.2 +79.2%

EBIT 17.1 12.3 +39.6%

EBIT margin 7.8% 6.7% +1.1 pp

H1 2013: stable upward performance

Increase in revenue by 19.8% to EUR 218.3m Higher sales volumes were partly offset by negative price effects Significant increase in earnings and margins – driven by

Latexx Partners and no adverse operational effects in H1 2013 EBIT impacted by higher depreciation (new capacities in

Thailand and consolidation effect of Latexx Partners) and impairment charge of EUR 0.6m on Brazilian customer base

Latexx Partners EPS accretive in H1 2013

Key Financials Sempermed

Q2 2013 Q2 2012 %

111.6 94.2 +18.4%

16.0 11.9 +33.9%

14.3% 12.7% +1.6 pp

-6.0 -3.4 +76.9%

10.0 8.6 +17.0%

9.0% 9.1% -0.1 pp

Industrial Sector: High profitability despite weak market environment


Semperflex

Sempertrans

Semperform

Revenue down by 5.8% due to weak market environment, especially Asia

Flexible capacity and cost management led to continued high profitability

Nearly unchanged EBITDA margin of 22.9% (H1 2012: 23.2%)

Revenue up by 10.0%: supported by end of strike in India, impacted by lower raw material prices

Strong profit growth and further margin improvement

EBITDA margin increased to 15.2% vs. 11.3% in H1 2012

Revenue and profit growth despite economic headwind

Volume increases were partly offset by negative price effects

EBITDA margin improved to 19.5% vs. 18.7% in H1 2012

in EUR m H1 2013

H1 2012 % Q2

2013 Q2

2012 %

Revenue 90.4 96.0 -5.8% 48.0 48.3 -0.5%

EBIT 14.8 16.9 -12.5% 7.9 8.7 -10.1%

EBIT margin 16.4% 17.6% -1.2 pp 16.4% 18.1% -1.7 pp

Strong double-digit margins in all segments

in EUR m H1 2013

H1 2012 % Q2

2013 Q2

2012 %

Revenue 78.4 71.3 +10.0% 41.2 32.3 +27.4%

EBIT 9.8 6.0 +63.0% 5.3 2.8 +91.0%

EBIT margin 12.5% 8.4% +4.1 pp 12.8% 8.6% +4.2 pp

in EUR m H1 2013

H1 2012 % Q2

2013 Q2

2012 %

Revenue 64.3 60.3 +6.6% 35.4 33.1 +6.9%

EBIT 9.7 8.5 +13.9% 6.3 5.3 +17.4%

EBIT margin 15.1% 14.2% +0.9 pp 17.7% 16.1% +1.6 pp

Strong cash flow, still net liquidity, very solid balance sheet


1) excl. non-controlling interests 2) H1 2012 adjusted, see notes of interim report

in EUR m H1 2013 H1 20122) % Cash flow from operating activities 52.6 45.9 +14.5%

Cash flow from investment activities -35.1 -16.7 +110.7%

Cash flow from financing activities -37.8 -17.1 +121.4%

Equity ratio above 50%

Still net liquidity

Increased Cash flow from operating activities

in EUR m 30.6.2013 31.12.2012 % 31.3.2013 Cash and cash equivalents 111.9 133.3 -16.1% 145.5

Bank liabilities 107.7 118.5 -9.1% 112.6

Net liquidity 4.2 14.8 -71.7% 32.9

in EUR m 30.6.2013 31.12.2012 % 31.3.2013

Total assets 815.2 824.5 -1.1% 867.4

Equity1) 411.1 406.2 +1.2% 427.7

Equity ratio 50.4% 49.3% +1.1pp 49.3%

Outlook

11

Outlook


Development of Semperit Group

Unchanged targets

Group: Continuation of overall satisfactory demand for all Semperit products – only affected by the usual seasonality in Q3 and Q4

Medical Sector: Further growth through integration of Latexx Partners, additional operational and organisational steps to support growth

Industrial Sector: Continuation of H1 2013 development in all industrial segments despite economic headwinds in most of the relevant markets

CAPEX: About EUR 50m in 2013 includes initial investments for expansion of Sempertrans plant in Poland

No economic rebound expected in general

Slight stimulation of demand in selective markets

Continuation of stable interest rates in the eurozone expected, confidence regarding the development of the Euro

Average double digit growth from 2010-2015 (CAGR) EBITDA margin of 12 - 15% EBIT margin of 8 - 11 %

Market view

Contact and Financial calendar


Investor Relations [email protected] +43 1 79777 - 210 www.semperitgroup.com/en/ir Modecenterstrasse 22 1031 Vienna, Austria

Financial calendar 2013 of Semperit November 12, 2013 Report on Q1-3 2013 Financial calendar 2014 of Semperit March 27,2014 Publication of FY 2013 and press conference April 29, 2014 Annual general meeting, Vienna May 6, 2014 Ex-dividend day May 8, 2014 Dividend payment day May 20, 2014 Report on Q1 2014 August 19, 2014 Report on H1 2014 November 18, 2014 Report on Q1-3 2014 Disclaimer

The information provided in this presentation does not constitute an offer for the sale of securities nor an invitation to submit an offer to purchase shares of Semperit AG Holding, but exclusively serves information purposes. The forecasts, plans and forward-looking statements contained in this report are based on the knowledge and information available and the assessments made at the time that this report was prepared. As is true of all forward-looking statements, these statements are subject to risk and uncertainties. As a result, the actual events may deviate significantly from these expectations. No liability whatsoever is assumed for the accuracy of projections or for the achievement of planned targets or for any other forward-looking statements.

APPENDIX

14

Significant improvements in revenue and earnings


1) 2012 figures adjusted, see notes of interim report

Highlights H1 2013

Highest revenue in a first half-year ever (+10.2% compared to H1 2012)

Material costs with a lower increase than revenue due to efficient raw material management

Personnel expenses grew due to rise in employees (esp. Latexx Partners takeover)

Other operating expenses went up in line with higher revenue

Increase in depreciation due to new capacities in Thailand (installed mainly throughout 2012), consolidation of Latexx Partners and an impairment charge of the Brazilian customer base (EUR 0.6m)

Financial Result declined slightly due to higher financial expenses

Tax rate fell slightly from 20.8% to 19.6%

in EUR m H1 2013

H1 20121) % Q2

2013 Q2

20121) %

Revenue 451.4 409.8 +10.2% 236.2 208.0 +13,6%

Other op. Income 12.4 15.5 -20.0% 5.9 6.2 -4.8%

Material costs -264.1 -255.2 +3.5% -133.1 -130.6 +1.9%

Personell expenses -76.6 -62.7 +22.2% -39.3 -32.7 +20.2%

Other op. expenses -68.0 -62.4 +9.0% -35.4 -29.9 +18.4%

EBITDA 65.8 53.9 +22.1% 36.4 29.6 +23.0%

Depreciation -22.1 -16.4 +34.8% -11.5 -8.6 +33,7%

EBIT 43.7 37.5 +16.5% 24.9 21.0 +18.6%

Financial Result -7.0 -5.7 +22.8% -4.0 -4.3 -7.0%

EBT 36.7 31.8 +15.4% 21.0 16.7 +25.7%

Income taxes -8.5 -7.9 +7.6% -5.2 -4.4 +18.2%

Earnings after tax 28.2 23.9 +18.0% 15.8 12.3 +28.5%

EPS (EUR) 1.36 1.16 +17,2% 0.76 0.60 +26.7%

Key Figures Income Statement

Continued financial strength


Highlights H1 2013

Balance sheet total declined by 1.1%

Cash and cash equivalents declined from EUR 133m to EUR 112m due to dividend payments, the acquisition of further Latexx Partners-shares and partial repayment of the framework loan

Improved capital structure

Equity ratio (excl. non-controlling interests) of 50.4% vs. 49.3% (12/2012)

Return on equity 13.6% (H1 2012: 12.2%), extrapolated for the full year

Increase in Trade Working Capital from EUR 212m to EUR 222m driven by higher business volume

in EUR m 30.6.2013 31.12.2012 % 31.3.2013

Fixed Assets 382.9 391.1 -2.1% 399.0

Inventories 154.2 142.5 +8.2% 159.4

Trade accounts receivable 131.8 120.2 +9.7% 128.7

Current assets incl. def. taxes 146.3 170.8 -14.3% 180.4

ASSETS 815.2 824.5 -1.1% 867.4

Key Figures Balance Sheet

in EUR m 30.6.2013 31.12.2012 % 31.3.2013

Equity1) 417.3 428.0 -2.5% 448.2

Liablities from shares 108.0 110.1 -1.9% 121.1

Provisions incl. social capital 63.4 64.8 -2.1% 66.9

Other liablities incl. def. tax 226.5 221.6 -2.2% 231.2

EQUITY & LIABILITIES 815.2 824.5 -1.1% 867.4

1) incl. non-controlling interests

Long-term financial facilities established


Highlights

Corporate Schuldschein loan issued in July 2013 (EUR 125m)

Tranches of the corporate Schuldschein loan mature in 2018, 2020 and 2023

Credit facilities in place in Austria (EUR 180m facility), no utilisation as of July 31, 2013

Local credit facilities in Malaysia and the US (in total EUR 16m equivalent) are rolled over regularly

Maturity profile of Schuldschein loan as of 31 July 2013

0

10

20

30

40

50

60

70

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

in EUR m